Common Names: wild leadwort
Plumbagin from Plumbago zeylanica inhibits tumor growth by targeting copper-dependent apoptosis in pancreatic cancer cells. Plumbagin prevents copper efflux, induces ROS production, and suppresses specific genes, suggesting its potential as a cancer treatment.
This study purified two water-soluble polysaccharides from Plumbago zeylanica L. and found that they have significant anti-inflammatory effects in THP-1 cells. These compounds could be potential anti-inflammatory agents.
Researchers studied the effectiveness of plumbagin in inhibiting cell growth, tumor metastasis, and inducing apoptosis in tongue squamous cell carcinoma. Findings may lead to new therapies for this type of cancer with a poor prognosis.
Plumbagin, extracted from Plumbago zeylanica L., inhibits growth and induces apoptosis in LoVo colon cancer cells. Mechanisms include cell cycle arrest and disruption of protein synthesis. Potential therapeutic for colon cancer.
This review examines the Unani system's understanding of dementia, focusing on phytochemistry, nootropic, and CNS activities. It suggests potential directions for future research and enhances our understanding of dementia.
Plumbagin, a molecule extracted from a medicinal herb, has been studied for its potential to treat Parkinson's disease (PD). This study found that plumbagin partially repairs the loss of dopaminergic neurons and improves behavioral impairment in mice with PD. It also inhibits inflammatory pathways and enhances autophagy. These results suggest that plumbagin has promise as a treatment agent for PD, but further studies are needed to confirm its effectiveness.